A rare case of synchronous multiple primary lung cancer with different responses to gefitinib

Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.

Uloženo v:
Podrobná bibliografie
Vydáno v:Respir Med Case Rep
Hlavní autoři: Liao, Che-Chi, Lin, Yu-Sen, Lin, Yu-Chao, Cheng, Chiao-Jen, Chen, Shuo-Chueh
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596341/
https://ncbi.nlm.nih.gov/pubmed/33145160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101270
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky